Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03988595 · ClinicalTrials.gov registry record · Phase 1
Exercise Treatment With Standard Therapy for Metastatic Breast Cancer
A Phase 1 study of Hormone Receptor Positive Metastatic Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
- 10
- Study locations
NCT03988595 is a Phase 1 study of Hormone Receptor Positive Metastatic Breast Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 54 participants. The trial reports 10 study locations across 4 states.
The verdict
NCT03988595, a Phase 1 study of Hormone Receptor Positive Metastatic Breast Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
- 10
- Study locations
Study Summary
This study will test any good and bad effects of aerobic exercise performed while you are receiving the usual first-line treatment for metastatic breast cancer. The researchers think that exercise helps delay the development of resistance to hormone therapy while slowing the growth of tumors.
Conditions Studied
Interventions
- OTHER Exercise Treatment
Study Locations (10)
New York
- Memorial Sloan Kettering Cancer Center @ Suffolk (Limited protocol activity) - Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Montefiore Health Systems (Montefiore Medical Center) (Data Collection Only) - The Bronx
- Memorial Sloan Kettering Nassau (Limited Protocol Activities) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale
Indiana
- Indiana University (Data Collection Only) - Indianapolis
Maryland
- Johns Hopkins Hospital (Data Collection Only) - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2019-06-12 |
| Est. Completion | 2026-08-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03988595
The ClinicalTrials.gov registry entry for NCT03988595 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hormone Receptor Positive Metastatic Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercise Treatment is the first listed.
NCT03988595 reports 10 study locations spanning 4 distinct geographic areas - top geographies include New York, New Jersey, Indiana.
Frequently Asked Questions
What is clinical trial NCT03988595 about?
NCT03988595 is a clinical study titled "Exercise Treatment With Standard Therapy for Metastatic Breast Cancer". This study will test any good and bad effects of aerobic exercise performed while you are receiving the usual first-line treatment for metastatic breast cancer. The researchers think that exercise helps delay the development of resistance to hormone therapy while slowing the growth of tumors.
What is the current status of trial NCT03988595?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2019-06-12. Estimated completion is 2026-08-01.
What conditions does trial NCT03988595 study?
This clinical trial studies the following conditions: Hormone Receptor Positive Metastatic Breast Cancer.
What interventions are being tested in trial NCT03988595?
The interventions under investigation include: Exercise Treatment (OTHER).
Who is sponsoring clinical trial NCT03988595?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03988595 being conducted?
This trial has 10 study locations across Indiana, Maryland, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.